Compound ID | 3624
Class: Protein synthesis inhibitor
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive, Gram-negative & Antimycobacterial |
| Mechanism of action: | Protein synthesis inhibitor. Aminoacyl-tRNA synthetase inhibitor (isoleucyl-tRNA synthetase [Ile-RS] inhibitor) |
| Target Pathogen: | Active against Staphylococcus aureus, Enterococcus sp., Streptococcus sp., Haemophilus influenzae, Escherichia coli, Mycoplasma sp., and Mycobacterium tuberculosis |
| Description: | Synthetic compound; analogues reported; also binds to fungal and parasitic aminoacyl-tRNA synthetases |
| Institute where first reported: | Cubist Pharmaceuticals, Inc. US |
| Year first mentioned: | 1997 |
| Development status: | Experimental |
| External links: | |
| Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/483208 |
| Citation: | https://patents.google.com/patent/WO1997005132A1/en?oq=WO%2f1997%2f005132 |
| Patent: | WO1997005132A1 |